Dan Dobreanu

5.9k total citations
42 papers, 584 citations indexed

About

Dan Dobreanu is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Dan Dobreanu has authored 42 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Dan Dobreanu's work include Cardiac Arrhythmias and Treatments (19 papers), Cardiac pacing and defibrillation studies (17 papers) and Atrial Fibrillation Management and Outcomes (15 papers). Dan Dobreanu is often cited by papers focused on Cardiac Arrhythmias and Treatments (19 papers), Cardiac pacing and defibrillation studies (17 papers) and Atrial Fibrillation Management and Outcomes (15 papers). Dan Dobreanu collaborates with scholars based in Romania, Sweden and Denmark. Dan Dobreanu's co-authors include Nikolaos Dagres, Jesper Hastrup Svendsen, Kristina H. Haugaa, Antonio Hernández‐Madrid, Carina Blomström‐Lundqvist, Torben Bjerregaard Larsen, Tatjana Potpara, Germanas Marinskis, Roland Richard Tilz and C. Blomström‐Lundqvist and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Dan Dobreanu

40 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Dobreanu Romania 14 504 92 49 43 40 42 584
Andrija Matetić Croatia 9 142 0.3× 58 0.6× 58 1.2× 41 1.0× 19 0.5× 50 304
Carina Blomström Lundqvist Sweden 11 593 1.2× 125 1.4× 46 0.9× 51 1.2× 19 0.5× 26 652
Tauseef Akhtar United States 10 242 0.5× 58 0.6× 19 0.4× 42 1.0× 11 0.3× 38 410
Angkawipa Trongtorsak United States 11 186 0.4× 48 0.5× 47 1.0× 25 0.6× 6 0.1× 54 323
Rose A. Hamershock United States 12 193 0.4× 35 0.4× 43 0.9× 33 0.8× 19 0.5× 27 328
Tomás Datino Spain 14 730 1.4× 110 1.2× 38 0.8× 89 2.1× 6 0.1× 74 841
James O. Coffey United States 14 724 1.4× 74 0.8× 73 1.5× 40 0.9× 19 0.5× 25 815
Ajit Mullasari India 12 281 0.6× 224 2.4× 29 0.6× 74 1.7× 12 0.3× 49 409
Nikhil Nalluri United States 12 327 0.6× 165 1.8× 107 2.2× 23 0.5× 24 0.6× 27 474
Allan Davies Australia 12 250 0.5× 114 1.2× 107 2.2× 44 1.0× 11 0.3× 56 397

Countries citing papers authored by Dan Dobreanu

Since Specialization
Citations

This map shows the geographic impact of Dan Dobreanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Dobreanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Dobreanu more than expected).

Fields of papers citing papers by Dan Dobreanu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Dobreanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Dobreanu. The network helps show where Dan Dobreanu may publish in the future.

Co-authorship network of co-authors of Dan Dobreanu

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Dobreanu. A scholar is included among the top collaborators of Dan Dobreanu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Dobreanu. Dan Dobreanu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kondo, Toru, Karola Jering, C. Jan Willem Borleffs, et al.. (2023). Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial. Circulation. 147(14). 1067–1078. 5 indexed citations
3.
Ostrominski, John W., Muthiah Vaduganathan, Brian Claggett, et al.. (2022). Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial. European Journal of Heart Failure. 24(10). 1892–1901. 25 indexed citations
4.
Scridon, Alina, Adina Huţanu, Laura Chinezu, et al.. (2019). Vascular protease‐activated receptor 4 upregulation, increased platelet aggregation, and coronary lipid deposits induced by long‐term dabigatran administration – results from a diabetes animal model. Journal of Thrombosis and Haemostasis. 17(3). 538–550. 10 indexed citations
5.
Rustamova, Yasmin & Dan Dobreanu. (2018). Biomarkers in heart failure: from the bedside back to biology. Revista română de medicină de laborator. 26(3). 267–270.
6.
7.
Fumagalli, Stefano, Tatjana Potpara, Torben Bjerregaard Larsen, et al.. (2017). Frailty syndrome: an emerging clinical problem in the everyday management of clinical arrhythmias. The results of the European Heart Rhythm Association survey. EP Europace. 19(11). 1896–1902. 50 indexed citations
8.
Tilz, Roland Richard, Tatjana Potpara, Jian Chen, et al.. (2017). Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey. EP Europace. 19(10). 1737–1742. 30 indexed citations
9.
Dobreanu, Dan, et al.. (2016). Echocardiographic evaluation of mechanical dyssynchrony in heart failure patients with reduced ejection fraction. Technology and Health Care. 24(s2). S587–S592. 2 indexed citations
10.
Potpara, Tatjana, Gregory Y.H. Lip, Torben Bjerregaard Larsen, et al.. (2016). Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of ‘valvular’ atrial fibrillation: results of the European Heart Rhythm Association Survey. EP Europace. 18(10). 1593–1598. 11 indexed citations
11.
12.
Scridon, Alina, et al.. (2015). Inflammation, a link between obesity and atrial fibrillation. Inflammation Research. 64(6). 383–393. 45 indexed citations
13.
Hernández‐Madrid, Antonio, Jesper Hastrup Svendsen, Gregory Lip, et al.. (2013). Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey. EP Europace. 15(6). 915–918. 30 indexed citations
14.
Lip, Gregory, et al.. (2013). Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey. EP Europace. 15(10). 1526–1532. 13 indexed citations
15.
Dobreanu, Dan, Jesper Hastrup Svendsen, Thorsten Lewalter, et al.. (2013). Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey. EP Europace. 15(8). 1223–1225. 33 indexed citations
16.
Dagres, N., et al.. (2013). Current investigation and management of patients with syncope: results of the European Heart Rhythm Association survey. EP Europace. 15(12). 1812–1815. 13 indexed citations
17.
Dobreanu, Dan, et al.. (2012). Atrial fibrillation ablation techniques. EP Europace. 14(10). 1515–1517. 4 indexed citations
18.
Bongiorni, Maria Grazia, Germanas Marinskis, Gregory Lip, et al.. (2012). How European centres diagnose, treat, and prevent CIED infections: Results of an European Heart Rhythm Association survey. EP Europace. 14(11). 1666–1669. 43 indexed citations
19.
Svendsen, Jesper Hastrup, Andreas Goette, Dan Dobreanu, et al.. (2012). Outpatient evaluation and management of patients with ventricular premature beats or non-sustained ventricular tachycardia. EP Europace. 14(2). 294–296. 6 indexed citations
20.
Dobreanu, Dan, et al.. (2012). Approach to cardiac resyncronization therapy. EP Europace. 14(9). 1359–1362. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrija Matetić Breakdown of academic impact, for papers by Carina Blomström Lundqvist Breakdown of academic impact, for papers by Tauseef Akhtar Breakdown of academic impact, for papers by Angkawipa Trongtorsak Breakdown of academic impact, for papers by Rose A. Hamershock Breakdown of academic impact, for papers by Tomás Datino Breakdown of academic impact, for papers by James O. Coffey Breakdown of academic impact, for papers by Ajit Mullasari Breakdown of academic impact, for papers by Nikhil Nalluri Breakdown of academic impact, for papers by Allan Davies
Rankless by CCL
2026